Pharma
Takeda Pharmaceutical Company Limited
1
Articles
Mentioned
Top Role
Apr 11, 2026
First Mention
Apr 11, 2026
Last Mention
0.95
Relevance Score
Coverage Timeline
April 2026
Sanofi’s $1.8B Insomnia Bet: What the Idorsia Deal Says About Sleep Drugs and Biopharma Valuation
Deals
Mentioned
Apr 11, 2026
Take it in context. Takeda’s $4 billion for orexin agonists, GSK’s $2 billion-plus for sleep-wake disorder assets, big sums, all structured with heavy milestone components.